3 Advantages of Using Pooled PBMCs to Detect and Quantify Pyrogens Mar 12, 2023 The primary method of testing pharmaceuticals for pyrogens since the 1960s has been the limulus amoebocyte lysate (LAL) test, which...
Regulatory Considerations When Sourcing Human PBMCs to Develop Advanced Therapies Jan 12, 2021 In the production of cell-based therapies, the quality and safety of peripheral blood mononuclear cells (PBMCs) and other raw materials...